While ARVC is classically attributed to desmosomal mutations, emerging evidence implicates voltage-gated sodium channel dysfunction, particularly SCN5A-encoded Nav1.5, as a critical co-driver of disease progression. The gene discussed is SCN5A; the disease is Arrhythmogenic right ventricular dysplasia.